Drug Use Investigation of Gadovist.
Drug Use Investigation of Gadovist
Sponsor: Bayer
This observational or N/A phase trial investigates Image Enhancement and Magnetic Resonance Imaging and is currently completed. Bayer leads this study, which shows 13 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2023 [monthly]
Completed
-
Nov 2018 — Jan 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Jul 2018 — Nov 2018 [monthly]
Completed
-
Jun 2018 — Jul 2018 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Dec 2017 — Feb 2018 [monthly]
Recruiting NA
-
Jun 2017 — Dec 2017 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .